US 11,939,326 B1
7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Antar Ahmed Abdelhamid Ahmed, Sohag (EG); and Amer A. Amer, Sohag (EG)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Nov. 10, 2023, as Appl. No. 18/388,756.
Application 18/388,756 is a division of application No. 18/241,383, filed on Sep. 1, 2023.
Int. Cl. C07D 417/12 (2006.01); A61P 35/00 (2006.01)
CPC C07D 417/12 (2013.01) [A61P 35/00 (2018.01)] 1 Claim
 
1. A method of treating inflammation in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a 7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound having the formula I:

OG Complex Work Unit Chemistry